VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 452 filers reported holding VANECK VECTORS ETF TR in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $58,560,000 | -4.7% | 2,000,000 | -13.1% | 58.95% | +153.2% |
| Q3 2019 | $61,467,000 | +69.2% | 2,301,286 | +42.0% | 23.28% | +5649.1% |
| Q1 2019 | $36,336,000 | +2.2% | 1,620,684 | -15.6% | 0.40% | -37.3% |
| Q3 2018 | $35,567,000 | -41.3% | 1,920,490 | -30.3% | 0.65% | -53.4% |
| Q1 2018 | $60,580,000 | +18713.7% | 2,756,165 | +19803.0% | 1.39% | +23000.0% |
| Q4 2017 | $322,000 | -99.9% | 13,848 | -99.9% | 0.01% | -99.9% |
| Q3 2017 | $393,144,000 | +19.3% | 17,123,008 | +14.7% | 8.06% | +18.5% |
| Q2 2017 | $329,537,000 | +13.4% | 14,924,720 | +17.1% | 6.80% | +15.6% |
| Q1 2017 | $290,642,000 | +0.1% | 12,741,900 | -8.2% | 5.88% | +8.6% |
| Q4 2016 | $290,424,000 | +23.5% | 13,882,565 | +56.0% | 5.41% | +0.6% |
| Q3 2016 | $235,219,000 | -20.4% | 8,899,700 | -16.5% | 5.38% | -21.3% |
| Q2 2016 | $295,364,000 | – | 10,659,100 | – | 6.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |